Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Clinical trial NCT00755703 · COMPLETED

Trial details

NCT number: NCT00755703
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza A Subtype H5N1 Infection

Start date: 2008-10-01
Primary completion: 2009-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.